CB
PFE icon

Chemical Bank’s Pfizer PFE Stock Holding History

Chemical Bank’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$9.41M Sell
229,071
-5,327
-2% -$212K 1.07% 20
2019
Q1 		$9.45M Buy
234,398
+1,405
+0.6% +$56.3K 1.07% 21
2018
Q4 		$9.65M Sell
232,993
-15,496
-6% -$643K 1.19% 15
2018
Q3 		$10.4M Sell
248,489
-5,020
-2% -$193K 1.08% 16
2018
Q2 		$8.73M Sell
253,509
-333
-0.1% -$11.4K 0.94% 20
2018
Q1 		$8.55M Sell
253,842
-23,273
-8% -$800K 0.93% 18
2017
Q4 		$9.52M Sell
277,115
-15,077
-5% -$514K 1.03% 18
2017
Q3 		$9.9M Sell
292,192
-3,456
-1% -$111K 1.1% 13
2017
Q2 		$9.42M Sell
295,648
-8,639
-3% -$272K 1.03% 15
2017
Q1 		$9.88M Sell
304,287
-17,602
-5% -$555K 1.1% 16
2016
Q4 		$9.92M Buy
321,889
+4,387
+1% +$134K 1.14% 15
2016
Q3 		$10.2M Buy
317,502
+7,334
+2% +$245K 1.38% 8
2016
Q2 		$10.4M Sell
310,168
-7,034
-2% -$224K 1.43% 5
2016
Q1 		$8.92M Sell
317,202
-11,998
-4% -$343K 1.25% 9
2015
Q4 		$10.1M Sell
329,200
-12,884
-4% -$405K 1.4% 5
2015
Q3 		$10.2M Sell
342,084
-10,316
-3% -$331K 1.47% 5
2015
Q2 		$11.2M Sell
352,400
-7,602
-2% -$248K 1.49% 6
2015
Q1 		$11.9M Buy
360,002
+1,519
+0.4% +$48.3K 1.55% 6
2014
Q4 		$10.6M Buy
358,483
+183,649
+105% +$5.27M 1.38% 9
2014
Q3 		$4.91M Sell
174,834
-1,352
-0.8% -$37.9K 0.85% 24
2014
Q2 		$4.96M Sell
176,186
-713
-0.4% -$20.3K 0.84% 22
2014
Q1 		$5.39M Sell
176,899
-29,678
-14% -$885K 0.97% 14
2013
Q4 		$6M Sell
206,577
-1,739
-0.8% -$50.6K 1.07% 15
2013
Q3 		$5.68M Sell
208,316
-26,440
-11% -$719K 1.1% 12
2013
Q2 		$6.24M Buy
+234,756
New +$6.49M 1.23% 10

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Chemical Bank's PFE Position: Q2 2019 in Review

Chemical Bank reduced its Pfizer (PFE) stake by 2.3% in Q2 2019, selling an estimated $212K and leaving 229,071 shares worth $9.41M. The position accounts for 1.07% of the portfolio, ranked #20.

Chemical Bank first reported a position in PFE in Q2 2013 and has held it in 25 quarters since. The position peaked at $11.9M in Q1 2015. 2,377 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Chemical Bank held 229,071 shares of Pfizer worth $9.41M as of Q2 2019.
  • Chemical Bank sold 5,327 Pfizer shares in Q2 2019, an estimated $212K.
  • Pfizer made up 1.07% of Chemical Bank's portfolio in Q2 2019, its #20 holding.
  • Chemical Bank first reported a position in Pfizer in Q2 2013 and has held it in 25 quarters since.
  • Chemical Bank's Pfizer position peaked at $11.9M in Q1 2015.
  • 2,377 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.